Cargando…

Targeting the Host Mitochondria as a Novel Human Cytomegalovirus Antiviral Strategy

Human cytomegalovirus (HCMV) exploits host mitochondrial function to promote viral replication. HCMV gene products have been described to directly interact and alter functional or structural aspects of host mitochondria. Current antivirals against HCMV, such as ganciclovir and letermovir, are design...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachman, Lauryn O., Zwezdaryk, Kevin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223864/ https://www.ncbi.nlm.nih.gov/pubmed/37243170 http://dx.doi.org/10.3390/v15051083

Ejemplares similares

Host Mitochondrial Requirements of Cytomegalovirus Replication
por: Monk, Chandler H., et al.
Publicado: (2020)

Inhibiting cytomegalovirus replication through targeting the host electron transport chain
por: Combs, Joseph A., et al.
Publicado: (2021)

Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
por: Bottino, Paolo, et al.
Publicado: (2023)

An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
por: Panda, Kingshuk, et al.
Publicado: (2023)

Role of immunometabolism during congenital cytomegalovirus infection
por: Zwezdaryk, Kevin J., et al.
Publicado: (2023)

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

The Human Cytomegalovirus Major Immediate-Early Proteins as Antagonists of Intrinsic and Innate Antiviral Host Responses
por: Paulus, Christina, et al.
Publicado: (2009)

The Cytomegalovirus Protein Kinase pUL97: Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting
por: Steingruber, Mirjam, et al.
Publicado: (2020)

The human cytomegalovirus terminase complex as an antiviral target: a close-up view
por: Ligat, G, et al.
Publicado: (2018)

Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts
por: Warner, Jessica A, et al.
Publicado: (2012)

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
por: Smith, Wendell, et al.
Publicado: (2013)

Human Cytomegalovirus Infection Dysregulates the Canonical Wnt/β-catenin Signaling Pathway
por: Angelova, Magdalena, et al.
Publicado: (2012)

US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection
por: Lee, Sungjin, et al.
Publicado: (2017)

Novel therapeutic strategies targeting mitochondria as a gateway in neurodegeneration
por: Trigo, Diogo, et al.
Publicado: (2022)

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
por: Zheng, Yucheng, et al.
Publicado: (2022)

Development of a CRISPR-Cas12a rapid diagnostic for human cytomegalovirus
por: Monk, Chandler H., et al.
Publicado: (2023)

Pathogenesis of human cytomegalovirus in the immunocompromised host
por: Griffiths, Paul, et al.
Publicado: (2021)

The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies
por: Wong, Kai Zhi, et al.
Publicado: (2018)

Antiviral strategies targeting herpesviruses
por: Dong, Haisi, et al.
Publicado: (2021)

Human Cytomegalovirus Cell Tropism and Host Cell Receptors
por: Gerna, Giuseppe, et al.
Publicado: (2019)

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
por: Krishna, B. A., et al.
Publicado: (2017)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
por: Gerold, Gisa, et al.
Publicado: (2013)

Mitochondria Targeting as an Effective Strategy for Cancer Therapy
por: Ghosh, Poorva, et al.
Publicado: (2020)

Mitochondria and Antiviral Immunity
por: Thomas, Sunil, et al.
Publicado: (2016)

Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Srinivasan, Kavya, et al.
Publicado: (2021)

Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
por: Sorriento, Daniela, et al.
Publicado: (2014)

Host Cell Factors as Antiviral Targets in Arenavirus Infection
por: Linero, Florencia N., et al.
Publicado: (2012)

The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection
por: Hong, Chien Tai, et al.
Publicado: (2016)

Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
por: Bauer, Lisa, et al.
Publicado: (2017)

Human Cytomegalovirus Strategies to Maintain and Promote mRNA Translation
por: Vincent, Heather A., et al.
Publicado: (2016)

Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection
por: Lee, Suki Man-Yan, et al.
Publicado: (2012)

Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug–Loaded Nanoformulations
por: S Allemailem, Khaled, et al.
Publicado: (2021)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021)

Strain-Dependent Restriction of Human Cytomegalovirus by Zinc Finger Antiviral Proteins
por: Lista, Maria Jose, et al.
Publicado: (2023)

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
por: Göhring, Katharina, et al.
Publicado: (2015)

Development of novel vaccines against human cytomegalovirus
por: Cui, Xinle, et al.
Publicado: (2019)

Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts
por: Da Cunha, Teresa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_475e217r9uqk9o4c9de6qoa52u